Dermaliq Therapeutics logo

Dermaliq Therapeutics

Wilmington, DE

Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The proprietary technology now owned by Dermaliq, called hyliQ™, is designed to allow cutaneous drug delivery with bioavailability. The technology enables the development of effective liquid drug products with exceptional cosmetic properties.

dermaliq.com

Company Details

Founded

2022

Employees

Between 5 - 10 employees

Raised

$30,000,000

Headquarters Location

Wilmington, DE

Public

No

Acquired

No

CEO

Frank LöscherFrank Löscher

Founders

Betsy Hughes-Formella
Betsy Hughes-Formella
Frank Löscher
Frank Löscher
Oliver Schlüter
Oliver Schlüter

Company Collections

These are collections Dermaliq Therapeutics is a part of. Click on the collection name to view similar companies.

Dermaliq Therapeutics' Industries

Dermaliq Therapeutics' Tech Stack

Company Collections For Dermaliq Therapeutics